Mild cognitive impairment, Subjective cognitive decline
Conditions
Interventions
MCI Population: Experimental Group:Head-mounted VR rehabilitation training for 20–30 minutes, 5 times per week, for a total of 4 weeks.
The HP G2 Reverb Omnicept headset (currently available on the ma
managing cognitive decline risk factors (reducing sedentary time, increasing physical activity and social engagement)
sleep monitoring and adjustment
emotional well-being and coping strategies
and managing underlying conditions like hypertension, diabetes, and hyperlipidemia.
MCI population: control group:All elderly participants in this study will receive standardized care for 4 weeks, 5 times per week, along with phased health education and lifestyle guidance covering: a
managing risk factors for cognitive decline such as reducing sedentary behavior, increasing physical activity and social engagement
addressing emotional well-being and coping strategies
and controlling underlying conditions like hypertension, diabetes, and hyperlipidemia.
SCD population: Experimental group:Head-mounted VR cognitive training for 20–30 minutes, 5 times per week, for a total of 4 weeks.
Utilizing the HP G2 Reverb Omnicept headset (currently available on t
Sponsors
School of Nursing, Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
55 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for MCI population: 1. Age 55-85 years old; 2. Primary school education or above, visual and hearing barrier-free, can cooperate with the completion of the assessment; 3. Overall cognitive function assessment: Mini-Task Mental State Examination Scale (MMSE) >=27 points and =26 points and SCD-Q9>=5 points; 4. Volunteer to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. History of neuropsychiatric diseases, such as cerebrovascular disease, depression, schizophrenia, drug dependence, intracranial tumors, refractory epilepsy, Parkinson's disease, normal pressure hydrocephalus, brain tumors and head trauma surgery, etc.; 2. Diseases of the heart, liver, kidney, hematopoietic system and endocrine system that seriously affect cognitive function; 3. Cranial magnetic resonance has infarct lesions, microbleeds and mass occupancy; 4. Those who are receiving other non-pharmacological interventions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MCI:Cognitive Function ;MCI: Activities of Daily Living (ADL) Scale;MCI: Imaging Acquisition;MCI:Physiological Data Signal Acquisition (EEG data: 5 minutes with eyes closed, 5 minutes with eyes open);MCI:Eye movement data collection (forward saccade reaction time, backward saccade reaction time, backward saccade error rate, eye movement trajectories, etc.);MCI:Functional Near-Infrared Device Evaluation;SCD: Cognitive Function ;SCD: Activities of Daily Living (ADL) Scale;SCD:Imaging Acquisition;SCD:Physiological Data Signal Acquisition (EEG data: 5 minutes with eyes closed, 5 minutes with eyes open);SCD:Eye movement data collection (forward saccade reaction time, backward saccade reaction time, backward saccade error rate, eye movement trajectories, etc.);SCD:Functional Near-Infrared Device Evaluation; | — |
Countries
China
Contacts
Public ContactBai Yamei
School of Nursing, Nanjing University of Chinese Medicine
Outcome results
None listed